Hemant Devidas Une, Lalita Bansidas Bhagure
firstname.lastname@example.org , email@example.com
Hemant Devidas Une1*, Lalita Bansidas Bhagure2
1Department of Pharmacology, Y. B. Chavan College of Pharmacy, Rouza Bagh, Aurangabad, Maharashtra, India.
2Department of Pharmacology, PhD Scholar, Y. B. Chavan College of Pharmacy, Rouza Bagh, Aurangabad, Maharashtra, India.
Volume - 15,
Issue - 3,
Year - 2022
Hematological malignancies for a very large percentage of cancers occurring the world over and lead to a very large number of deaths each year. It is not just the disease but also the currently available cure which are equally responsible for the side effects and discomfort experienced by the patients. The side effects of the current chemotherapeutic agents' available range from mouth ulcers, diarrhea, temporary hair loss, rashes, nausea, vomiting, and fatigue to low blood cell counts, increased risk of infections, graft versus host disease, tumor lysis syndrome, differentiation syndrome, and difficulty in conceiving. Due to these myriad side effects researchers and on a continuous lookout for newer treatment alternatives. For most developing countries one of the most attractive options is offered by herbals or plant-based medicines. One such herb is Cyclea peltata. It is a climbing shrub found aplenty in southern and eastern India. It has been used traditionally to cure lots of minor ailments. This paper explores the possibility of using the root extract for the treatment of leukemia. To do this, the extracts of the roots were prepared in different organic solvents to ensure complete extraction of all phytoconstituents fractions. The extracts were then tested on 3 different human cell lines. The potential cause of the antileukemic potential of the plant was also hypothesized and proven by carrying out antioxidant studies using the DPPH free radical scavenging assay. The probable active constituents were identified using the liquid chromatography-mass spectrometry assessment, wherein the responsible fractions were successfully identified. The studies showed that the alkaloid and phenolic phytoconstituents were responsible for the antileukemic potential via their antioxidant activity. This lays down the groundwork of offering a new and safer treatment option that could be further explored to be made into one having actual clinical outreach.
Cite this article:
Hemant Devidas Une, Lalita Bansidas Bhagure. The Anti-leukemic Potential of Cyclea peltata as Validated by Phytochemical and Cell Line Studies. Research Journal of Pharmacy and Technology. 2022; 15(3):1064-0. doi: 10.52711/0974-360X.2022.00178
Hemant Devidas Une, Lalita Bansidas Bhagure. The Anti-leukemic Potential of Cyclea peltata as Validated by Phytochemical and Cell Line Studies. Research Journal of Pharmacy and Technology. 2022; 15(3):1064-0. doi: 10.52711/0974-360X.2022.00178 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-3-21
1. World Health Organization. Cancer. Accessed October 25, 2020. https://www.who.int/news-room/fact-sheets/detail/cancer
2. Leukemia - Cancer Stat Facts. SEER. Accessed October 25, 2020. https://seer.cancer.gov/statfacts/html/leuks.html
3. Roy M, Mukherjee A, Mukherjee S, Biswas J. Phytochemicals as an adjuvant in leukemia therapy. In: Leukemia Causes, Symptoms & Treatment. Vol 1.:14.
4. gknation. Chemotherapy and Drug Therapy. Published February 26, 2015. Accessed October 25, 2020. https://www.lls.org/leukemia/acute-myeloid-leukemia/treatment/chemotherapy-and-drug-therapy
5. Hosseini A, Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomedicine. 2015; 5(2):84-97.
6. Ishikawa H, Saeki T, Otani T, et al. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr. 2006; 136(3 Suppl):816S-820S. doi:10.1093/jn/136.3.816S
7. Tanaka S, Haruma K, Yoshihara M, et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr. 2006; 136(3 Suppl):821S-826S. doi:10.1093/jn/136.3.821S
8. Lv Y, So K-F, Wong N-K, Xiao J. Anti-cancer activities of S-allylmercaptocysteine from aged garlic. Chin J Nat Med. 2019; 17(1):43-49. doi:10.1016/S1875-5364(19)30008-1
9. Deguchi A. Curcumin targets in inflammation and cancer. Endocr Metab Immune Disord Drug Targets. 2015; 15(2):88-96. doi:10.2174/1871530315666150316120458
10. Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients. 2019; 11(10). doi:10.3390/nu11102376
11. Wang Y, Yu J, Cui R, Lin J, Ding X. Curcumin in Treating Breast Cancer: A Review. J Lab Autom. 2016; 21(6):723-731. doi:10.1177/2211068216655524
12. Dai D, Zhang C-F, Williams S, Yuan C-S, Wang C-Z. Ginseng on Cancer: Potential Role in Modulating Inflammation-Mediated Angiogenesis. Am J Chin Med. 2017; 45(1):13-22. doi:10.1142/S0192415X17500021
13. Majeed F, Malik FZ, Ahmed Z, Afreen A, Afzal MN, Khalid N. Ginseng phytochemicals as therapeutics in oncology: Recent perspectives. Biomed Pharmacother Biomedecine Pharmacother. 2018; 100:52-63. doi:10.1016/j.biopha.2018.01.155
14. Shirakami Y, Shimizu M. Possible Mechanisms of Green Tea and Its Constituents against Cancer. Mol Basel Switz. 2018; 23(9). doi:10.3390/molecules23092284
15. Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M. Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells. Mol Cells. 2018; 41(2):73-82. doi:10.14348/molcells.2018.2227
16. Shine VJ, Latha PG, Shyamal S, et al. Gastric antisecretory and antiulcer activities of Cyclea peltata (Lam.) Hook. f. & Thoms. in rats. J Ethnopharmacol. 2009; 125(2):350-355. doi:10.1016/j.jep.2009.04.039
17. Shine VJ, Latha PG, Suja SNR, Anuja GI, Raj G, Rajasekharan SN. Ameliorative effect of alkaloid extract of Cyclea peltata (Poir.) Hook. f. & Thoms. roots (ACP) on APAP/CCl4 induced liver toxicity in Wistar rats and in vitro free radical scavenging property. Asian Pac J Trop Biomed. 2014; 4(2):143-151. doi:10.1016/S2221-1691(14)60223-9
18. Kumar Y, Haridasan K, Rao RR (North-EHU. Ethnobotanical notes on certain medicinal plants among some Garo people around Balphakram sanctuary in Meghalaya [India]. Bull Bot Surv India India. Published online 1982. Accessed October 25, 2020. https://agris.fao.org/agris-search/search.do?recordID=IN8202366
19. Singh SG, Nishteswar K, Patel BR, Nariya M. Comparative antipyretic and analgesic activities of Cissampelos pareira Linn. and Cyclea peltata (Lam.) Hook. F. & Thomas. Ayu. 2016; 37(1):62-66. doi:10.4103/ayu.AYU_208_14
20. Odaya Kumar P, Venkata Rao V, Srinivasu K, Sivanageswararao M, Mariyapraveenmani P. Anti-bacterial activities of aqueous and ethanolic cyclea peltata leave extracts in tirunelveli, tamilnadu, india. Asian J Res Biol Pharm Sci. 2016; 4(2):60-67.
21. Chellappan DR, Joseph J, Balasubramanian P. Pharmacognostical, antioxidant and antiulcer screening of Cyclea peltata roots. Rev Bras Farmacogn. 2011; 21(6):1096-1103. doi:10.1590/S0102-695X2011005000168
22. S JC, S MM, Ramesh R. Evaluation of the wound healing activity of Caesalpinia bonducella and cyclea peltata extracts in experimentally induced diabetic rats. Int J Pharm Pharm Sci. Published online October 2, 2017:211-217. doi:10.22159/ijpps.2017v9i10.19788
23. Mustafaanand PH. In-vitro plantlets regeneration from callus cultures of cyclea peltata (Lam) Hooks & Thoms - A medicinal plant. Int J Pharm Biol Sci. 2018; 8(2):225-229.
24. Padyana S, S RR, Saraswathi S. Ethno-medico-botany of moodabidri range in child health care. Int Res J Pharm. 2019; 9(12):88-91. doi:10.7897/2230-8407.0912298
25. Bhandary MJ, Chandrashekar KR, Kaveriappa KM. Medical ethnobotany of the Siddis of Uttara Kannada district, Karnataka, India. J Ethnopharmacol. 1995; 47(3):149-158. doi:10.1016/0378-8741(95)01274-h
26. Jayaraman S, Variyar EJ. Immunomodulatory, anticancerous & antioxidant activities of cyclea peltata (lam.) Hook.f. and thomson. Int J Pharm Pharm Sci. Published online October 1, 2019:40-46. doi:10.22159/ijpps.2019v11i10.35248
27. Vijayan FP, Rani VKJ, Vineesh VR, Sudha KS, Michael MM, Padikkala J. Protective effect of Cyclea peltata Lam on cisplatin-induced nephrotoxicity and oxidative damage. J Basic Clin Physiol Pharmacol. 2007; 18(2):101-114. doi:10.1515/jbcpp.2007.18.2.101
28. Sukanya BCV, Bhat PR. Phytochemical, antimicrobial, antioxidant and immunomodulatory studies of leaf extracts of Cyclea peltata (Lam.) Hook. f. & Thomson. GSC Biol Pharm Sci. 2019; 9(3):052-063. doi:10.30574/gscbps.2019.9.3.0228
29. Maniarasan U, Keerthiga M, Nagarajan N. Comparative investigation on antimicrobial and phytochemical profiling of Cyclea peltata and Tiliocora acuminate. J Appl Biol Biotechnol. 2020; 8(3):57-63. doi:10.7324/JABB.2020.803011
30. Hullatti KK, Gopikrishna UV, Kuppast IJ. Phytochemical investigation and diuretic activity of Cyclea peltata leaf extracts. J Adv Pharm Technol Res. 2011; 2(4):241-244. doi:10.4103/2231-4040.90880
31. Christina AJM, Packia Lakshmi M, Nagarajan M, Kurian S. Modulatory effect of Cyclea peltata Lam. on stone formation induced by ethylene glycol treatment in rats. Methods Find Exp Clin Pharmacol. 2002; 24(2):77-79. doi:10.1358/mf.2002.24.2.677130
32. Ambrose C, Varghese C, Munisamy P, et al. Effect of ethanolic extract of Cyclea peltata Lam on a hypercholesterolemic rat model. Pharmacogn Mag. 2005; 1(2):59.
33. M. S. S, S. P, S. H, K. D. In vivo antidiabetic potential of cyclea peltata in streptozotocin‑induced‑diabetic rats. Asian J Pharm Clin Res. 2015; 8(1):103-108.
34. J M, D A, K. S. S. Anticancer efficacy of Cyclea peltata on human breast carcinoma cells. Indian J Tradit Knowl. 2018; 17(1):162-167.
35. Kupchan SM, Yokoyama N, Thyagarajan BS. Menispermaceae alkaloids II. The alkaloids of cyclea peltata diels. J Pharm Sci. 1961; 50(2):164-167. doi:10.1002/jps.2600500216
36. Hooper SN, Chandler RF. Herbal remedies of the maritime Indians: Phytosterols and triterpenes of 67 plants. J Ethnopharmacol. 1984; 10(2):181-194. doi:10.1016/0378-8741(84)90002-3
37. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990; 82(13):1107-1112. doi:10.1093/jnci/82.13.1107
38. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006; 1(3):1112-1116. doi:10.1038/nprot.2006.179
39. Blois MS. Antioxidant Determinations by the Use of a Stable Free Radical. Nature. 1958; 181(4617):1199-1200. doi:10.1038/1811199a0
40. Leitão GG, Leitão SG, Vilegas W. Quick preparative separation of natural naphthopyranones with antioxidant activity by high-speed counter-current chromatography. Z Naturforschung C J Biosci. 2002; 57(11-12):1051-1055. doi:10.1515/znc-2002-11-1217
41. Mari A, Lyon D, Fragner L, et al. Phytochemical composition of Potentilla anserina L. analyzed by an integrative GC-MS and LC-MS metabolomics platform. Metabolomics. 2013; 9(3):599-607. doi:10.1007/s11306-012-0473-x
42. Haq SH, Al-Ruwaished G, Al-Mutlaq MA, et al. Antioxidant, Anticancer Activity and Phytochemical Analysis of Green Algae, Chaetomorpha Collected from the Arabian Gulf. Sci Rep. 2019; 9(1):18906. doi:10.1038/s41598-019-55309-1
43. Grigalius I, Petrikaite V. Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones. Mol J Synth Chem Nat Prod Chem. 2017; 22(12). doi:10.3390/molecules22122169